13.45
Surgery Partners Inc Aktie (SGRY) Neueste Nachrichten
A Look At Surgery Partners (SGRY) Valuation After A Difficult Year For Shareholders - Yahoo Finance
CORRECTED: Distalmotion Accelerates US Commercial Momentum in Ambulatory Surgery Centers - Yahoo Finance UK
Distalmotion Accelerates US Commercial Momentum in Ambulatory Surgery Centers - Yahoo Finance
Surgery Partners stock (US85701Q1031): Earnings date in focus ahead of August report - AD HOC NEWS
Deals tracker: Medtronic to acquire SPR Therapeutics for $650M - Modern Healthcare
Surgery Partners Inc stock (US85701Q1031): earnings momentum and M&A reshape outlook - AD HOC NEWS
[SCHEDULE 13G/A] Surgery Partners, Inc. Amended Passive Investment Disclosure - Stock Titan
Trading Systems Reacting to (SGRY) Volatility - Stock Traders Daily
5 Revealing Analyst Questions From Surgery Partners’s Q1 Earnings Call - Yahoo Finance
Jefferies Remains Bullish on Surgery Partners (SGRY) Post Q1 - Insider Monkey
Surgery Partners Delivered Solid Q1 Beat Amid Stabilizing Portfolio, RBC Says - Moomoo
BofA Securities Maintains Surgery Partners(SGRY.US) With Buy Rating, Maintains Target Price $17.5 - Moomoo
RBC Capital Maintains Surgery Partners(SGRY.US) With Buy Rating, Maintains Target Price $20 - Moomoo
Ambulatory Surgical Centers Market to Reach US$ 162.13 Billion - openPR.com
A Quick Look at Today's Ratings for Surgery Partners(SGRY.US), With a Forecast Between $16.25 to $21 - Moomoo
MSN Money - MSN
A Look At Surgery Partners (SGRY) Valuation After Reaffirmed Guidance And Positive First Quarter Results - Sahm
Is Surgery Partners’ (SGRY) Q1 Beat And Reaffirmed 2026 Outlook Altering The Investment Case? - Yahoo Finance
Stronger Q1 Results And Reaffirmed Outlook Might Change The Case For Investing In Surgery Partners (SGRY) - Sahm
Number of shareholders of Surgery Partners, Inc. – LSX:A14YWP - TradingView
Surgery Partners outlines 2026 revenue of $3.35B-$3.45B and adjusted EBITDA of at least $530M as portfolio optimization targets mid-2026 announcement - MSN
Surgery Partners SGRY Q1 2026 Earnings Transcript - AOL.com
Surgery Partners price target raised to $17 from $15 at Jefferies - TipRanks
Jefferies Maintains Surgery Partners(SGRY.US) With Buy Rating, Raises Target Price to $17 - Moomoo
FMR LLC holds 2.19M SGRY shares (1.7%) — Surgery Partners (NYSE: SGRY) - Stock Titan
Surgery Partners Q1 2026 Earnings Call Transcript - Sahm
Surgery Partners, Inc. (NASDAQ:SGRY) Q1 2026 Earnings Call Transcript - Insider Monkey
Surgery Partners Q1 2026 earnings preview - MSN
KeyBanc Maintains Surgery Partners(SGRY.US) With Hold Rating - Moomoo
Surgery Partners Q1 2026 slides: revenue beats amid regulatory pressures By Investing.com - Investing.com Australia
SGRY Q1 Deep Dive: Stable Margins and Physician Recruitment Offset Volume Headwinds - The Globe and Mail
Surgery Partners Balances Growth Ambitions With Rising Headwinds - TipRanks
Surgery Partners : Quarterly Report for Quarter Ending March 31, 2026 (Form 10-Q) - marketscreener.com
Surgery Partners Q1 Earnings Call Highlights - Yahoo Finance
Surgery Partners (SGRY) Q1 2026 revenue rises as net loss narrows - Stock Titan
Surgery Partners Releases Q1 2026 Financial Results - AlphaStreet
Surgery Partners | 8-K: SURGERY PARTNERS, INC. ANNOUNCES FIRST QUARTER 2026 RESULTS REAFFIRMS FULL YEAR 2026 GUIDANCE - Moomoo
Surgery Partners (SGRY) reports Q1 loss, tops revenue estimates - MSN
Surgery Partners Narrows Slips to a Loss in Q1 2026, Beats Estimates - AlphaStreet
Surgery Partners Q1 2026 slides: revenue beats amid regulatory pressures - Investing.com
Earnings call transcript: Surgery Partners Q1 2026 earnings beat forecasts By Investing.com - Investing.com Australia
Earnings call transcript: Surgery Partners Q1 2026 earnings beat forecasts - Investing.com UK
Surgery Partners Q1 Swings to Adjusted Net Loss, Revenue Rises; Full-Year 2026 Revenue Guidance Reaffirmed - marketscreener.com
Surgery Partners reports Q1 adjusted EPS (3c), consensus (14c) - TipRanks
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):